Investigational Drug Information for GDC-0077
✉ Email this page to a colleague
What is the development status for investigational drug GDC-0077?
GDC-0077 is an investigational drug.
There have been 188 clinical trials for GDC-0077.
The most recent clinical trial was a Phase 3 trial, which was initiated on December 13th 2016.
The most common disease conditions in clinical trials are Breast Neoplasms, Carcinoma, and Lymphoma. The leading clinical trial sponsors are Genentech, Inc., National Cancer Institute (NCI), and Hoffmann-La Roche.
There are three US patents protecting this investigational drug and fifty-five international patents.
Summary for GDC-0077
| US Patents | 3 |
| International Patents | 55 |
| US Patent Applications | 19 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 3 (2016-12-13) |
| Vendors | 26 |
Recent Clinical Trials for GDC-0077
| Title | Sponsor | Phase |
|---|---|---|
| Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer | National Cancer Institute (NCI) | Phase 1 |
| Testing the Safety and Efficacy of the Addition of A New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Etoposide and Cisplatin) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma | National Cancer Institute (NCI) | Phase 1/Phase 2 |
| Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer | Foundation Medicine | Phase 2 |
Clinical Trial Summary for GDC-0077
Top disease conditions for GDC-0077
Top clinical trial sponsors for GDC-0077
US Patents for GDC-0077
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| GDC-0077 | See Plans and Pricing | Benzoxazepin oxazolidinone compounds and methods of use | Genentech, Inc. (South San Francisco, CA) | See Plans and Pricing |
| GDC-0077 | See Plans and Pricing | Benzoxazepin oxazolidinone compounds and methods of use | Genentech, Inc. (South San Francisco, CA) | See Plans and Pricing |
| GDC-0077 | See Plans and Pricing | Benzoxazepin oxazolidinone compounds and methods of use | Genentech, Inc. (South San Francisco, CA) | See Plans and Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for GDC-0077
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| GDC-0077 | Argentina | AR105238 | 2035-07-02 | See Plans and Pricing |
| GDC-0077 | Australia | AU2016287463 | 2035-07-02 | See Plans and Pricing |
| GDC-0077 | Australia | AU2020204418 | 2035-07-02 | See Plans and Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
